Type 2 Diabetes
Conditions
Keywords
aerobic training, resistance training, type 2 diabetes, therapy
Brief summary
The purposes of this study are: a) to compare the effects of supervised programs of aerobic training or resistance training on the metabolic control of type 2 diabetes; b) to investigate some potential pathophysiologic and molecular mechanisms underlying these effects; c) to assess whether some changes may persist over time after termination of the supervised programs.
Detailed description
Meta-analyses of studies which evaluated the effects of interventions based upon structured exercise programs in patients with type 2 diabetes show that regular physical activity may improve glycosylated haemoglobin (HbA1c) by 0.6-0.7%. Most studies assessed the effects of aerobic exercise. However, recent data suggest that resistance training may result in similar effects. It seems likely that these beneficial results are obtained through different molecular mechanisms by aerobic training and resistance training. Consequently, these exercise modalities could be synergistic in improving the metabolic abnormalities in these subjects. On the other hand, comparison data are very limited. Aims of the protocol are to compare the effects of aerobic training or resistance training on the metabolic control of type 2 diabetes and to investigate some potential pathophysiologic and molecular mechanisms underlying these effects. The study will be carried out in 40 sedentary type 2 diabetic patients without diabetic complications, aged 40-70 yr, with body mass index (BMI) between 24-36 kg/m2 and HbA1c between 6.5-9.0%. Admitted diabetes treatments will be diet and oral hypoglycemic agents. Subjects will be assigned, by a randomization schedule weighted by baseline BMI and fitness, to 2 groups of supervised exercise: aerobic training or resistance training. Training programs will have a similar volume and will be scheduled in three 60 min sessions per week for 4 months. During the study subjects will be instructed to follow an isocaloric diet. Before and at the end of the exercise training the following will be assessed: HbA1c (primary outcome), plasma glucose, lipid profile, blood pressure, insulin sensitivity (glucose clamp), body composition (Dual energy X-ray absorptiometry, DEXA), liver and muscle fat content (magnetic resonance imaging), expression in the muscle of some genes involved in ATP production, mitochondrial biogenesis and substrate utilization, markers of inflammation, oxidative stress and early vascular damage, peak oxygen uptake (VO2peak) during a maximal exercise test, other exercise tests, tissue oxygen extraction during exercise (Near-infrared spectroscopy, NIRS), energy expenditure and physical activity in daily life (metabolic Holter and questionnaire). Monitoring of blood glucose will also be carried out over a 48h period, comprising an exercise session (Continuous Glucose Monitoring System). Metabolic features, exercise tests, body composition, daily physical activity and expression of relevant genes in the muscle will also be assessed 1 yr after completion of the training programs, to establish whether some changes may persist over time.
Interventions
BEHAVIORALAerobic Training
The aerobic training group will exercise on cardiovascular training equipment. The workload will be gradually increased up to 60% of the reserve heart rate. Subjects will exercise 3 times per week for 60 min in the Fitness Centre of the Exercise and Sport Science School. Training will be carried out in small groups, under the supervision of personal trainers. During the study subjects will be instructed to follow an isocaloric diet.
BEHAVIORALResistance Training
The resistance training group will perform different exercises on weight machines and free weights to exercise upper and lower extremity muscles. Participants will perform 8-10 different exercises each session, alternating abdominal, upper and lower extremity exercises. Subjects will exercise 3 times per week for 60 min in the Fitness Centre of the Exercise and Sport Science School. Training will be carried out in small groups, under the supervision of personal trainers. During the study subjects will be instructed to follow an isocaloric diet.
Sponsors
Universita di Verona
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
40 Years to 70 Years
Healthy volunteers
No
Inclusion criteria
* BMI between 24-36 kg/m2; * HbA1c between 6.5-9.0%; * diabetes diagnosis must have been made at least 1 yr previously; * admitted diabetes treatments will be diet and oral hypoglycemic agents; * baseline physical activity, estimated by the IPAQ questionnaire, lower than 1000 MET min per week; * baseline body weight stable (changes lower than 2 kg in the last 2 months).
Exclusion criteria
* moderate-severe somatic or autonomic neuropathy; * coronary heart disease; * peripheral or cerebral vascular disease; * preproliferative or proliferative retinopathy or chronic renal failure (serum creatinine \>1.4 mg/dl in females; \>1.5 mg/dl in males); * therapy with beta-blocker drugs; * smokers; * acute clinically significant intercurrent diseases; * inability to perform the scheduled physical activity programs.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in haemoglobin A1c (HbA1c) levels | 4 months | The measurement of HbA1c is carried out with a DCCT (Diabetes Control and Complications Trial)-aligned method. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in body composition | 4 months | Assessment by DEXA (Dual energy X-ray absorptiometry) |
| Change in fasting plasma glucose levels | 4 months | — |
| Change in total cholesterol levels | 4 months | — |
| Change in HDL-cholesterol levels | 4 months | — |
| Change in LDL-cholesterol levels | 4 months | — |
| Change in triglycerides levels | 4 months | — |
| Change in blood pressure | 4 months | — |
| Change in insulin sensitivity | 4 months | Measured by euglycemic hyperinsulinemic clamp |
| Change in energy expenditure | 4 months | Measured by indirect calorimetry |
| Change in antidiabetic medications | 4 months | Class and dosage of blood-glucose lowering drugs are recorded before and at the end of the protocol. |
| Change in body weight | 4 months | — |
| Change in beta-cell function | 4 months | Measured by OGTT (Oral Glucose Tolerance Test) |
| Change in energy expenditure through voluntary physical activity | 4 months | Energy expenditure is estimated through metabolic Holter (Sense Wear Armband) and IPAQ (International physical activity questionnaire). |
| Change in peak oxygen uptake | 4 months | Measured during an incremental exercise test |
| Change in tissue oxygen extraction | 4 months | Measured by NIRS (Near-infrared spectroscopy) during an incremental test exercise |
| Change in liver and muscle fat content | 4 months | Measured by Magnetic Resonance Imaging |
| Change in blood glucose during and after exercise | 48 hours | Measured by continuous glucose monitoring system |
| Muscle strength | 4 months | Measured by 1RM (one-repetition maximum) test |
| Change in 6 minutes walk distance | 4 months | This test measures the number of meters that can be walked in 6 minutes over a 30 m course. It is a simple field test to assess aerobic functional capacity. |
| Change in flexibility | 4 months | Measured by sit and reach test and back scratch test |
| Changes in expression in the muscle of some genes involved in ATP production, mitochondrial biogenesis and substrate utilization | 4 months | mRNA analysis with multiplex tandem real-time PCR of fine needle aspirates obtained from the vastus lateralis muscle |
| Compliance | 4 months | Attendance at the scheduled sessions is recorded for each patient. |
Outcome results
None listed